يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Hepatitis C, Chronic virology"', وقت الاستعلام: 2.11s تنقيح النتائج
  1. 1

    المساهمون: Nuffield Department of Medicine [Oxford, UK] (Big Data Institute), University of Oxford, University of Copenhagen = Københavns Universitet (UCPH), The Wellcome Trust Centre for Human Genetics [Oxford], Ecole Polytechnique Fédérale de Lausanne (EPFL), Université de Lausanne = University of Lausanne (UNIL), Swiss Institute of Bioinformatics [Lausanne] (SIB), Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), University of Glasgow, Queen Mary University of London (QMUL), University of Nottingham, UK (UON), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), STOP-HCV Consortium, Ball, J., Brainard, D., Burgess, G., Cooke, G., Dillon, J., Gore, C., Guha, N., Halford, R., Herath, C., Holmes, C., Howe, A., Hudson, E., Irving, W., Khakoo, S., Klenerman, P., Koletzki, D., Martin, N., Massetto, B., Mbisa, T., McHutchison, J., McKeating, J., Miners, A., Murray, A., Shaw, P., Spencer, CCA, Targett-Adams, P., Thomson, E., Vickerman, P., Zitzmann, N.

    المصدر: Nature Communications
    Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
    STOP-HCV Consortium 2021, ' Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure ', Nature Communications, vol. 12, no. 1, 6105 . https://doi.org/10.1038/s41467-021-25649-6
    Nature Communications, 2021, 12 (1), pp.6105. ⟨10.1038/s41467-021-25649-6⟩
    Nature communications, vol. 12, no. 1, pp. 6105

    وصف الملف: PDF; text; application/pdf

  2. 2
    دورية أكاديمية
  3. 3

    المساهمون: Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Physiopathologie du système immunitaire (Inserm U1223), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Unité de biostatistiques, CRLCC Val d'Aurelle - Paul Lamarque, Physiopathologie des Maladies Inflammatoires de l'Intestin, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé, Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Agence de la biomédecine [Saint-Denis la Plaine], Service Néphrologie et transplantation rénale Adultes [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Néphrologie et Transplantation rénale [CHRU-lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de Néphrologie - Immunologie Clinique [Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-PRES Université de Toulouse, Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Institut de Chimie du CNRS (INC)-Institut de Recherche pour le Développement (IRD), Unité fonctionnelle d’éthique et médecine légale [AP-HP Hôpital Necker Enfants malades], Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]

    المصدر: Journal of Hepatology
    Journal of Hepatology, 2019, 70 (5), pp.831-838. ⟨10.1016/j.jhep.2018.12.036⟩
    Journal of Hepatology, Elsevier, 2019, 70 (5), pp.831-838. ⟨10.1016/j.jhep.2018.12.036⟩

    مصطلحات موضوعية: Male, 0301 basic medicine, MESH: Antiviral Agents / therapeutic use, Kidney transplant recipients, [SDV]Life Sciences [q-bio], MESH: Hepatitis B, Chronic / virology, Hepacivirus, Virus Replication, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, Interferon, MESH: Hepatitis C, Chronic / virology, Kidney transplantation, Graft Survival, MESH: Hepatitis B virus / drug effects, virus diseases, Middle Aged, MESH: Kidney Transplantation / mortality, Hepatitis B, Prognosis, MESH: Case-Control Studies, MESH: Hepatitis C, Chronic / drug therapy, 3. Good health, MESH: Hepacivirus / drug effects, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, 030211 gastroenterology & hepatology, medicine.drug, Adult, Hepatitis B virus, medicine.medical_specialty, MESH: Graft Survival, Hepatitis C virus, Antiviral Agents, Virus, 03 medical and health sciences, Hepatitis B, Chronic, MESH: Hepacivirus / physiology, Internal medicine, medicine, Humans, chronic hepatitis C, chronic hepatitis B, Hepatitis, Hepatology, business.industry, MESH: Adult, MESH: Hepatitis B virus / physiology, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Hepatitis C, Chronic, medicine.disease, Kidney Transplantation, 030104 developmental biology, MESH: Virus Replication / drug effects, Viral replication, Case-Control Studies, business, MESH: Female, MESH: Hepatitis B, Chronic / drug therapy

  4. 4
  5. 5
  6. 6

    المساهمون: German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), German Centre for Infection Research (DZIF), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), L'Institut hospitalo-universitaire de Strasbourg (IHU Strasbourg), Institut National de Recherche en Informatique et en Automatique (Inria)-l'Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD)-Les Hôpitaux Universitaires de Strasbourg (HUS)-La Fédération des Crédits Mutuels Centre Est (FCMCE)-L'Association pour la Recherche contre le Cancer (ARC)-La société Karl STORZ, Nouvel Hôpital Civil de Strasbourg, University of Copenhagen = Københavns Universitet (UCPH), University of Alberta, University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Yale School of Medicine [New Haven, Connecticut] (YSM), Heidelberg University, Université de Lausanne = University of Lausanne (UNIL), Helmholtz Centre for Infection Research (HZI), Rockefeller University [New York], University of Freiburg [Freiburg], National Institute of Infectious Diseases [Tokyo], univOAK, Archive ouverte, TwinCore, Zentrum für experimentelle und klinische Infektionsforchung GmbH, Feodor-Lynen-Str.7, 30625 Hannover, Germany.

    المصدر: Virus research, vol. 248, pp. 53-62
    Bartenschlager, R, Baumert, T F, Bukh, J, Houghton, M, Lemon, S M, Lindenbach, B D, Lohmann, V, Moradpour, D, Pietschmann, T, Rice, C M, Thimme, R & Wakita, T 2018, ' Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy : Considerations for scientists and funding agencies ', Virus Research, vol. 248, pp. 53-62 . https://doi.org/10.1016/j.virusres.2018.02.016
    Virus Research
    Virus Research, 2018, 248, pp.53-62. ⟨10.1016/j.virusres.2018.02.016⟩
    Virus research
    Netherlands

    وصف الملف: application/pdf

  7. 7

    المساهمون: STOP-HCV Consortium, Barnes, E., Ball, J., Brainard, D., Burgess, G., Cooke, G., Dillon, J., Foster, G.R., Gore, C., Guha, N., Halford, R., Herath, C., Holmes, C., Howe, A., Hudson, E., Irving, W., Khakoo, S., Klenerman, P., Koletzki, D., Martin, N., Massetto, B., Mbisa, T., McHutchison, J., McKeating, J., McLauchlan, J., Miners, A., Murray, A., Shaw, P., Simmonds, P., Spencer, CCA, Targett-Adams, P., Thomson, E., Vickerman, P., Zitzmann, N., National Institute for Health Research, Medical Research Council (MRC), Medecins Sans Frontieres (MSF)

    المصدر: Nature genetics
    Nature genetics, vol. 49, no. 5, pp. 666-673

    وصف الملف: application/pdf

  8. 8

    المساهمون: Swiss HIV Cohort Study, Battegay, M., Bernasconi, E., Boni, J., Bucher, H., Burgisser, P., Calmy, A., Cattacin, S., Cavassini, M., Dubs, R., Egger, M., Elzi, L., Fischer, M., Flepp, M., Fontana, A., Francioli, P., Furrer, H., Fux, C., Gorgievski, M., Gu, H., Hirsch, H., Hirschel, B., Ho, I., Kahlert, C., Kaiser, L., Karrer, U., Kind, C., Klimkait, T., Ledergerber, B., Martinetti, G., Martinez, B., Mu, N., Nadal, D., Opravil, M., Paccaud, F., Pantaleo, G., Rauch, A., Regenass, S., Rickenbach, M., Rudin, C., Schmid, P., Schultze, D., Schupbach, J., Speck, R., Taffe, P., Telenti, A., Trkola, A., Vernazza, P., Weber, R., Yerly, S., University of Zurich, Telenti, A

    المصدر: Hepatology, vol. 53, no. 5, pp. 1446-1454
    Hepatology (Baltimore, Md.)

    وصف الملف: application/pdf

  9. 9
  10. 10

    المساهمون: Heidelberg University, Department of Infectious Diseases [Heidelberg, Germany], Heidelberg University Hospital [Heidelberg], Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Universität Heidelberg [Heidelberg] = Heidelberg University, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Hannover Medical School [Hannover] (MHH), German Center for Infection Research [Heidelberg, Germany] (DZIF), University Hospital Freiburg, Albert-Ludwigs-Universität Freiburg, This project was supported by grants from the Deutsche Forschungsgemeinschaft (TRR179-TP17, FOR1202-TP3 to Volker Lohmann, TRR179-TP9, FOR1202-TP1 to Ralf Bartenschlager, TRR179-TP1 to Robert Thimme, and TRR179-TP2 to Christoph Neumann-Haefelin). This work was supported by a grant from the Excellence Cluster Cellular Networks of University of Heidelberg (to Alexander H. Dalpke and Volker Lohmann)., The authors thank Rahel Klein, Ulrike Herian, Uta Haselmann, and Jutta Mohr for excellent technical assistance and Vibor Laketa for microscopy support. We are grateful to the Electron Microscopy Core Facility of the University of Heidelberg for providing access to their equipment and thanks to Dr Charlotta Funaya and Dr Stefan Hillmer for technical support in electron microscopy work. A plasmid encoding TLR3 was a kind gift from T. Espevik, NTNU, Trondheim, Norway. In addition, we thank Daniel Lamarre for helpful discussions., Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Universität Heidelberg [Heidelberg]

    المصدر: Gastroenterology
    Gastroenterology, 2018, 154 (8), pp.2237-2251.e16. ⟨10.1053/j.gastro.2018.03.020⟩
    Gastroenterology, WB Saunders, 2018, 154 (8), pp.2237-2251.e16. ⟨10.1053/j.gastro.2018.03.020⟩

    مصطلحات موضوعية: MESH: RNA, Double-Stranded/isolation & purification, 0301 basic medicine, MESH: Immunity, Innate, MESH: Interferons/immunology, MESH: Toll-Like Receptor 3/metabolism, viruses, Hepacivirus, MESH: Hepatitis C, Chronic/virology, Virus Replication, Exosomes, medicine.disease_cause, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, Interferon, MESH: RNA, Double-Stranded/immunology, Toll-like receptor, MESH: Hepatocytes/metabolism, RIG-I, Gastroenterology, MDA5, 3. Good health, Cell biology, MESH: Interferons/metabolism, MESH: Host-Pathogen Interactions/immunology, Host-Pathogen Interactions, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, RNA, Viral, MESH: Extracellular Vesicles/metabolism, Signal Transduction, medicine.drug, MESH: Toll-Like Receptor 3/immunology, MESH: Hepatitis C, Chronic/blood, Hepatitis C virus, Primary Cell Culture, Biology, MESH: Virus Replication/immunology, Virus, Cell Line, MESH: Primary Cell Culture, Extracellular Vesicles, 03 medical and health sciences, MESH: RNA, Viral/isolation & purification, Virology, medicine, Humans, MESH: RNA, Viral/immunology, MESH: Extracellular Vesicles/immunology, RNA, Double-Stranded, MESH: Hepatitis C, Chronic/immunology, MESH: Humans, Hepatology, MESH: Hepatocytes/immunology, MESH: RNA, Viral/metabolism, MESH: Signal Transduction/immunology, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Hepatitis C, Chronic, Immunity, Innate, Toll-Like Receptor 3, MESH: Cell Line, Escape, 030104 developmental biology, MESH: Hepacivirus/physiology, Viral replication, TLR3, Hepatocytes, Interferons, Rab27a, MESH: RNA, Double-Stranded/metabolism